Confidentiality and Non-Disclosure Basics When Sourcing Beauty

September 21, 2026 | CapsulesBiotech | 3 views
Confidentiality and Non-Disclosure Basics When Sourcing Beauty

Most brands sign a confidentiality form because the factory sends one, not because they have decided what they need to protect. The form is a starting point, but the risk is what sits outside it: the brief, the formula, the shade, the launch date, the retailer plan. A leak of any of those can cost more than the product, & a generic document does not cover them by wishing they were included.

This article sets out what a beauty brand should protect when it briefs a manufacturer, how to scope a non-disclosure that actually fits, & what to put in the brief so the document does real work. It is written for the founder or buyer who is about to send a specification to a factory for the first time, not for the lawyer who will finalise the wording.

Why confidentiality is a sourcing question, not a legal formality

The reason it belongs to sourcing is timing. The brief leaves the brand before the contract is signed, often during a sample request, & that is the moment the most sensitive material moves. A factory that receives a formula, a shade reference, & a launch calendar has more of the brand's plan than the brand may realize, & a form signed after the brief has already left is closing the door once the horse is gone.

The second reason is leverage. A brand with one supplier has more to lose from a leak than a brand with three, because the one supplier may also serve a rival in the same category. The non-disclosure should reflect that exposure, & a standard form that handles every factory the same ignores the difference between a commodity pack & a signature formula.

The practical point is to decide the scope before the first message, not after the first sample. The brand that knows what it must protect can write a brief that protects it, & the factory can work within the line rather than discovering it later as a restriction that slows the project.

What you are actually protecting when you brief a factory

The obvious item is the formula, but it is rarely the first to leave. The brief carries the concept, the target audience, the price point, the launch window, the retailer or marketplace, & the reference product the brand wants to beat. Each of those is a piece of commercial intelligence, & a competitor that learns the launch date can pre-empt the shelf.

The formula itself is a second layer. For a proven base the brand may be protecting only the final composition; for a custom development it is protecting the development work, the test data, & the claim support that cost a season to build. A factory that sees all of that can brief a rival without ever copying a single line, because the intelligence is in the plan, not the document.

The third layer is the supply detail: the source of a rare oil, the name of a fragrance house, the tool that defines the pack. A leak here lets a rival source the same story at a lower cost, & the brand loses the differentiation it paid to build. The brief should mark each layer, because a single "confidential" stamp on the whole file protects none of them well.

The two sides of an NDA: what the factory owes you, what you owe it

A non-disclosure is not one-way in practice, even when it is written that way. The factory owes the brand silence on the brief, the formula, & the plan. The brand owes the factory restraint on what it publishes about the line, the capacity, & the pricing, because a factory's commercial detail is also sensitive, & a brand that leaks it loses the trust it needs to source well.

The factory's duty should be specific: no use of the brief outside the project, no disclosure to a sister company without consent, no mention to a rival in the same category. A clause that says only "keep it secret" is hard to enforce, because it does not say what secret means or who may not hear it. The brand should name the prohibited uses rather than hope the word covers them.

The brand's duty is easier to forget. A brand that names its factory in a press release, or posts the pack before the launch, may expose the line the factory was asked to protect, & the conflict can void the protection the brand thought it had. The brief should state what the brand may publish & when, so the two duties do not collide at launch.

Scope: naming what is confidential, not hoping it is

Scope is the weakness of most forms. A document that calls the whole relationship confidential protects nothing, because a court or a factory cannot act on a word that means everything. The brand should list the items: the formula, the specification, the brief, the artwork, the launch date, the source list, & the test data, each named so the duty has an edge.

The exclusions matter as much as the inclusions. Information already public, already known to the factory, or independently developed should be carved out, because a clause that tries to cover what is already free is the one a factory will refuse or ignore. A tight scope is more enforceable than a broad one, & it tells the factory exactly where the line sits.

For a buyer the test is whether a new hire at the factory could read the brief & know what not to forward. A scope written as a list makes that clear; a scope written as a sentiment does not. The brand should write the list before the brief is sent, not during the dispute that follows a leak.

Term & survival after the project ends

A confidentiality duty that expires with the contract is a duty that lapses exactly when the risk grows, because a failed launch or a moved project leaves the brief in a factory the brand no longer works with. The term should survive the relationship by a period that matches the life of the intelligence, which for a formula is longer than for a pack.

The survival period should differ by item. A launch date loses value in a season, so a short cover is enough; a formula or a tool holds value for years, so the cover should run past the last batch. A single term for all items either over-protects the trivial or under-protects the critical, & the brief should split them.

The return or destruction of material is the second point. When a project ends, the brand should be able to ask for the brief, the samples, & the unused artwork to be returned or destroyed, & the factory should confirm in writing. A duty that survives but leaves the file on a shared drive is a duty with no teeth, & the brand should require the confirmation rather than assume it.

The brief itself as a confidential artifact

The brief is the artifact most often sent without protection, because it feels like a working document rather than a secret. In truth it is the densest piece of intelligence the brand produces, & it should carry a confidentiality note, a recipient limit, & a version that can be recalled. A brief sent to five people at a factory with no marking is a brief the brand cannot track.

The version control is the part that saves the brand later. A brief that changes without a version number lets a factory claim it worked to an old copy, & the brand cannot prove otherwise. The brief should carry a date, a version, & a list of who holds it, so the confidential artifact is also a controlled one.

The practical step is to send the brief as a marked PDF rather than a loose email thread, & to name the individuals rather than the company. A document addressed to a role is a document anyone in that role may open, & a brand that wants control should narrow the list to the people who must see it.

Subcontractors & the leak you did not name

The leak most brands miss is the subcontractor. A factory may pass the brief to a printer, a mould shop, or a filler it does not own, & each of those sees the sensitive detail without signing the brand's document. The non-disclosure should require the factory to bind its subcontractors to the same duty, or the protection stops at the factory's door.

The second gap is the trader. A material or a pack bought through a middleman may carry the brand's specification to a party the brand never named, & the middleman has no duty to the brand at all. The brief should state which items may be subcontracted & which may not, so the factory knows the line before it forwards the file.

For a buyer the control is a clause that flows down. The factory warrants that every party it uses is bound to the same confidentiality, & the brand may ask for the evidence. A clause that covers only the factory leaves the brief travelling to places the brand cannot see, which is where most leaks actually happen.

When confidentiality meets a formula you do not own

A confidentiality duty collides with ownership when the brand briefs a factory with a formula the brand did not develop. If the formula belongs to a former manufacturer, the new factory may already hold it, & a non-disclosure cannot create a secret that already exists. The brand should confirm ownership before it claims protection, or it will ask a factory to guard what it already knows.

The licensing route is the clean one. Where the brand licences a formula, the licence should state what the factory may see, what it may make, & what it may not pass on, & the non-disclosure should sit on top of that licence rather than beside it. The two documents should agree, because a conflict between them is the gap a leak walks through.

The custom development is simpler in theory: the brand owns the work, so the duty protects it cleanly. In practice the brand should still confirm that the development files, the test data, & the claim support are returned on exit, because a custom formula is only confidential if the brand holds the only copy. The ownership point is covered in our IP protection article.

Confidentiality exposures compared across the project

The table below sets the common exposures against what leaks, who might receive it, & the control that closes the gap. It is a comparison to brief from, not a fixed list, because the exposure shifts as the project moves from sample to launch.

ExposureWhat can leakWho might receive itControl that closes it
The first briefConcept, audience, launch dateThe factory sales teamA marked, versioned PDF to named people
The formulaComposition, actives, sourceLab, filler, subcontractorA flow-down duty to each party
The artworkPack, shade, claim copyPrinter, traderA no-subcontract clause for artwork
The source listRare oil, fragrance house, toolA rival via the supply chainA named-supplier confidentiality
The test dataStability, claim supportAny party with the fileA return or destroy on exit
The capacityRun size, lead time, pricingThe brand's own postsA publish-window restriction
The toolMould shape, drawingA rival via the toolmakerA toolmaker confidentiality
The ended projectThe whole brief, retainedA former factoryA survival term past last batch

The rows are a comparison, not fixed values, & the exposure a brand faces depends on its category & its plan to stay or move. A brand that works the list before the brief is sent avoids the late discovery that the item it forgot is the item the factory already forwarded, & that discovery is the costly kind.

A practical NDA checklist for a beauty buyer

The document should be short but complete. It should name the confidential items, the prohibited uses, the flow-down to subcontractors, the survival term per item, the return or destroy on exit, & the publish window for the brand. Each item is a task with a name, & a task with a name is a task that gets done, where a shared understanding often does not survive the first delay.

The dispute route belongs in the same document. If a leak is found, the clause should say who proves it, who pays for the loss, & what remedy applies, because a confidentiality dispute is exactly when the two sides disagree about harm. Settling it in advance is worth more than negotiating it after the launch week is already spent.

For a buyer the document is the confidentiality risk made manageable. A duty written down but not scoped is a wish; a duty scoped with items & terms is a brief the brand can actually protect, & it is the difference between a quiet launch & a copied one the brand cannot explain to its retailer.

What to put in the brief

Brief the confidentiality as a named duty with a scope, not as a stamp on the cover. List the items, set the survival term per item, require the flow-down to subcontractors, & state the publish window, so the factory works inside a line it can see rather than guessing at one it cannot.

  • The confidential items, named: formula, brief, artwork, source list, test data.
  • The prohibited uses, including work for a rival in the same category.
  • The subcontractors covered by a flow-down duty.
  • The survival term per item, longer for formula than for launch date.
  • The return or destroy of material on exit, with written confirmation.
  • The brand's own publish window, so the two duties do not collide.
  • The ownership of any formula that is not the brand's development.
  • The dispute route, including proof, loss, & remedy.

Then keep the brief versioned & sent to named people only, & review it when a subcontractor is added or a move is planned. A confidentiality question asked at the brief is a clause in a document; the same question asked after a leak is a loss the brand cannot recover, & the brief is what decides which of the two the brand gets.

Where our capability fits

We take the brief under a confidentiality scope the brand sets, we bind our subcontractors to the same duty, & we return or destroy the material on exit with a written confirmation. Where the brand owns the formula we hold only the copy the project needs, & where the brand licences it we work inside the licence rather than beside it.

We work with brands on private label (your brand on a proven base), OEM/ODM contract manufacturing & full custom formula development, & the confidentiality scope is agreed at the brief stage so the plan is protected before the first sample. Our lines include a custom formula face serum, a custom blue copper peptide serum & custom softgel face serum capsules, all produced with the same confidentiality discipline a new brand needs.

Tell us what you plan to brief & which items are most sensitive, & we will come back with the scope, the flow-down, & the survival term before any file leaves your hands. Start at our inquiry page, email capsulebiotech@163.com, or message the right team on WhatsApp: Capsule Series (capsules only) +86 158-7655-5319, Cosmetics Series (serum, hair care, body care, fragrance) +86 158-7655-5319. The choice between licensing an existing formula & building a new one is set out in our licensing guide.

General manufacturing information, not regulatory or legal advice. Confidentiality scope, survival terms, flow-down duties & ownership of development vary by contract & by project, & the applicable position should be confirmed for each engagement before a brief is shared.


Start Your Skincare Capsule Project

Contact our team today for a free consultation and custom formulation quote.

Contact Us Now